Glennon R A, Ablordeppey S Y, Ismaiel A M, el-Ashmawy M B, Fischer J B, Howie K B
Department of Medicinal Chemistry, School of Pharmacy, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0540.
J Med Chem. 1994 Apr 15;37(8):1214-9. doi: 10.1021/jm00034a020.
Two problems that have hampered sigma receptor research are (i) a lack of high-affinity agents and (ii) the recent identification of multiple populations of sigma receptors (i.e., sigma 1 and sigma 2 sites). Recently, several high-affinity sigma ligands have been identified, and the term superpotent sigma ligands has been coined to describe agents with Ki values of < 1 nM. We have previously shown that appropriately N-substituted phenylalkylamines bind at sigma receptors with high affinity. In the present investigation, we examine the structure-affinity relationships of these phenylalkylamine derivatives for sigma 1 binding and describe some of the first superpotent sigma 1 ligands. A binding model was developed to account for the structural features of the phenylalkylamines that appear to be important for the interaction of these agents with sigma 1 sites.
阻碍σ受体研究的两个问题是:(i)缺乏高亲和力的试剂;(ii)最近发现了多种类型的σ受体(即σ1和σ2位点)。最近,已鉴定出几种高亲和力的σ配体,并且创造了“超强效σ配体”一词来描述Ki值<1 nM的试剂。我们之前已经表明,适当的N-取代苯烷基胺以高亲和力结合于σ受体。在本研究中,我们研究了这些苯烷基胺衍生物与σ1结合的结构-亲和力关系,并描述了一些首批超强效σ1配体。开发了一种结合模型来解释苯烷基胺的结构特征,这些特征似乎对这些试剂与σ1位点的相互作用很重要。